This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Adistem Ltd., Tithon Biotech Inc.. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2021
Title: Vasilis Paspaliaris: Innovator in Stem Cell Research
Introduction
Vasilis Paspaliaris is a notable inventor based in Malvern East, Australia. He has made significant contributions to the field of stem cell research, holding two patents that showcase his innovative approaches to medical treatments.
Latest Patents
His latest patents include "Cells expressing parathyroid hormone 1 receptor and uses thereof." This patent discloses pluripotent stem cells cultured with one or more peptides and methods for isolating these stem cells. It also outlines methods for targeting the stem cells to specific regions within an organism. Furthermore, it describes the use of these isolated stem cells for improving fertility, promoting hair growth, treating or preventing skin conditions, addressing bone disorders, treating malignancies, and managing neurological disorders. Another significant patent is the "Method of treatment of type 2 diabetes," which provides a method for treating type 2 diabetes by administering a polypeptide comprising thymosin or an active fragment or variant thereof.
Career Highlights
Throughout his career, Vasilis has worked with various companies, including Tithon Biotech Inc. and Adistem Ltd. His work in these organizations has contributed to advancements in biotechnology and medical treatments.
Collaborations
Vasilis has collaborated with notable individuals in his field, including James Thornton and Brett Langan. These partnerships have likely enhanced his research and development efforts.
Conclusion
Vasilis Paspaliaris is a prominent figure in stem cell research, with patents that reflect his innovative spirit and dedication to improving medical treatments. His contributions continue to influence the field and offer hope for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile